Looking For A Better Entry Point, BMO Downgrades Zoetis Shares
Citing upcoming risks and not enough upside, BMO Capital Markets analyst Alex Arfaei has downgraded Zoetis Inc (NYSE: ZTS) to Market Perform.
“Although we expect a good 2Q17, we doubt it will meaningfully change the company's long-term growth prospects. With consensus estimates rising to meet ours, ZTS seems like a crowded long. While we recognize potential upside drivers, at these levels, we believe they are balanced by downside risk,” said Arfaei.
3 Key Takeaways
In 2016, BMO viewed Zoetis as a company with a very durable and resilient business. However, Arfaei no longer sees this as a case and believes BMO’s 2016 theses has materialized.
While BMO still expects Zoetis to have a solid Q2 report, Arfaei does not believe it will have a large enough impact on its long-term theses.
Arfaei sees a very balanced risk/reward opportunity with Zoetis.
Potential Rewards: Better-than-expected U.S. livestock recovery, growth in emerging markets, and U.S. tax reform.
Potential Risks: Slower-than-expected U.S. livestock recovery, Zoetis could struggle entering into emerging markets, the emergence of antibiotic-resistant bacteria.
Year to date, Zoetis is up 16 percent.
Latest Ratings for ZTS
Jun 2017 | BMO Capital | Downgrades | Outperform | Market Perform |
May 2017 | CL King | Initiates Coverage On | Buy | |
Mar 2017 | Craig-Hallum | Initiates Coverage On | Buy |
View More Analyst Ratings for ZTS
View the Latest Analyst Ratings
See more from Benzinga
Tesaro Is A Top Rumor Mill Stock Right Now; Here Is A Timeline Of The Chatter
Tesla Reigns Supreme In Electric Vehicle Space, But Ford And General Motors Still In The Race
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
